Chris Ohlgart

skip to Main Content
skip to Footer

Ohlgart, Chris

christopher.ohlgart@lw.com

+1.312.876.6591

Profile

Christopher Ohlgart is a tax associate in the Chicago office of Latham & Watkins.

Mr. Ohlgart advises clients on a range of US federal income tax matters, particularly on structuring domestic and international mergers and acquisitions, tax-free reorganizations, joint ventures, restructurings, and financing transactions.

Mr. Ohlgart also advises on equity and debt offerings, as well as the formation and operation of corporations, partnerships, and limited liability companies.

Experience

Mr. Ohlgart’s experience includes representing:

Publicly traded and privately held corporations, LLCs, and partnerships in buy-side and sell-side domestic and cross-border/international asset and equity acquisitions
Publicly traded and privately held corporations in taxable and tax-free mergers
Private equity funds in connection with structuring and operational issues and acquisitions and dispositions
Publicly traded corporations in equity and debt offerings

Qualifications

Bar Qualification

Illinois
Texas

Education

LL.M. in Taxation, New York University School of Law, 2015
JD, Loyola University Chicago School of Law, 2013
BA, Michigan State University, 2010

Languages Spoken

English

Practices

Modern building with square balconies seen from below. Modern architecture.

January 2, 2024 Our Work

Latham & Watkins Advises on USI, Inc.’s US$620 Million Senior Notes Offering

Firm represents the initial purchasers in the offering by the insurance broker.

Airport

December 21, 2023 Our Work

Latham & Watkins Advises AAR in Acquisition of Triumph Group's Product Support Business

Firm represents global aerospace and defense aftermarket solutions company on transaction to expand customer base and global footprint.

November 30, 2023 Our Work

Latham Advises on Tata Technologies’ US$365 Million IPO

July 7, 2023 Our Work

Latham & Watkins Advises Hyatt Hotels on US$600 Million Bond Offering

April 26, 2023 Our Work

Latham & Watkins Advises Assertio Holdings in Acquisition of Spectrum Pharmaceuticals

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.